GET THE APP

Nutritional Deficiencies in IBD Patients: Risk Factors, Assessment and Dietary Management
Journal of Inflammatory Bowel Diseases & Disorders

Journal of Inflammatory Bowel Diseases & Disorders

ISSN: 2476-1958

Open Access

Perspective - (2025) Volume 10, Issue 2

Nutritional Deficiencies in IBD Patients: Risk Factors, Assessment and Dietary Management

Micheal Handsbro*
*Correspondence: Micheal Handsbro, Department of Biology, Queensland University of Technology, Queensland, Australia, Email:
Department of Biology, Queensland University of Technology, Queensland, Australia

Received: 01-May-2025, Manuscript No. jibdd-25-165632; Editor assigned: 03-May-2025, Pre QC No. P-165632; Reviewed: 17-May-2025, QC No. Q-165632; Revised: 22-May-2025, Manuscript No. R-165632; Published: 29-May-2025 , DOI: 10.37421/2476-1958.2025.10.246
Citation: Handsbro, Micheal. “Nutritional Deficiencies in IBD Patients: Risk Factors, Assessment and Dietary Management.” J Inflamm Bowel Dis 10 (2025): 246.
Copyright: © 2025 Handsbro M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Introduction

Inflammatory Bowel Disease (IBD), encompassing conditions such as Crohnâ??s disease and ulcerative colitis, is characterized by chronic inflammation of the gastrointestinal tract, leading to a variety of symptoms including diarrhea, abdominal pain, and weight loss. These symptoms, coupled with the effects of long-term medication and the underlying disease process, often result in nutritional deficiencies in patients. Malnutrition in IBD can significantly impact disease outcomes, with consequences ranging from impaired growth in pediatric patients to worsened quality of life and reduced response to therapy in adults. Understanding the risk factors, assessing nutritional status, and implementing appropriate dietary management strategies are critical in improving overall health and disease control in IBD patients [1].

Description

Several factors contribute to nutritional deficiencies in IBD patients. The inflammatory nature of the disease itself plays a central role by increasing the body’s metabolic demands and reducing nutrient absorption. Inflammatory cytokines, which are elevated in IBD, can interfere with nutrient metabolism and lead to malabsorption. Additionally, IBD patients often experience gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain, which can reduce food intake and further exacerbate nutritional deficits. The disease can also affect specific areas of the digestive tract, such as the small intestine in Crohn’s disease, which is particularly important for nutrient absorption, or the colon in ulcerative colitis, where fluid and electrolytes are absorbed [2]. Surgical interventions, including resection of affected bowel segments, can result in further malabsorption and an increased risk of deficiencies, especially of fat-soluble vitamins and minerals. Common nutritional deficiencies in IBD patients include those of iron, vitamin B12, folate, vitamin D, calcium, and zinc. Iron deficiency anemia is particularly prevalent in IBD patients, often due to chronic blood loss from intestinal bleeding, malabsorption, and the increased need for iron during active disease. Vitamin B12 deficiency is commonly seen in patients with ileal involvement or after ileal resection, as the ileum is the primary site for vitamin B12 absorption. Similarly, deficiencies in vitamin D and calcium are widespread in IBD patients, especially those with active disease or those on corticosteroid therapy, which can impair calcium absorption and bone mineralization. Zinc deficiency is another concern due to impaired absorption, and folate levels can be affected by both the disease and medications such as methotrexate [3].

The assessment of nutritional status in IBD patients requires a comprehensive approach. Routine monitoring of body weight, growth parameters in children, and biochemical markers such as serum albumin, hemoglobin, and specific vitamins and minerals is essential. Clinical assessment should also include screening for signs of malnutrition, such as muscle wasting, fatigue, and edema. More specialized tests, such as vitamin D levels, bone mineral density measurements, and tests for fat-soluble vitamins, may be necessary depending on the individual’s disease profile. Furthermore, a detailed dietary history is crucial in understanding food intake, gastrointestinal symptoms, and any dietary restrictions that might contribute to deficiencies. Dietary management in IBD aims to address nutritional deficiencies while managing the symptoms and inflammatory processes of the disease. In patients with mild to moderate disease, dietary modifications can help improve nutritional status and reduce symptoms. A well-balanced, nutrient-dense diet rich in fruits, vegetables, lean proteins, and whole grains can provide essential vitamins and minerals, although the specific dietary needs may vary depending on the type of IBD and disease activity. For instance, low-residue diets may be helpful during flare-ups to reduce gastrointestinal irritation, while fiber-rich diets may be beneficial during remission to support gut health. In some cases, specialized diets, such as the low FODMAP diet, have shown promise in managing symptoms like bloating and diarrhea, though their impact on disease inflammation requires further investigation [4].

In cases of significant deficiencies, oral supplements or enteral nutrition may be required. Iron supplements are commonly prescribed for iron deficiency anemia, while vitamin D and calcium supplementation is often necessary to prevent bone demineralization. For vitamin B12 deficiency, regular injections or high-dose oral supplements may be indicated, particularly for patients with ileal involvement. Enteral nutrition, which provides balanced nutrient intake through liquid formulas, can be an effective tool in IBD management, particularly for children, as it not only addresses malnutrition but may also induce disease remission, especially in Crohn’s disease [5].

Conclusion

In conclusion, nutritional deficiencies are a common and significant concern in IBD patients, with the potential to worsen disease outcomes and quality of life. The underlying mechanisms of malabsorption, increased nutrient loss, and decreased intake due to disease symptoms all contribute to the development of these deficiencies. A comprehensive approach to nutritional assessment, coupled with personalized dietary management strategies, is essential in mitigating these risks. Early identification of deficiencies and timely intervention with supplements or dietary adjustments can significantly improve both nutritional status and disease control. As research continues to explore the intricate relationship between diet and disease activity, a tailored, patient-centered approach to nutrition will remain a cornerstone of effective IBD management.

Acknowledgment

None.

Conflict of Interest

None.

References

  1. Gerasimidis, K., P. McGrogan and C. A. Edwards. "The aetiology and impact of malnutrition in paediatric inflammatory bowel disease." J Hum Nutr Diet 24 (2011): 313-326.

Google Scholar Cross Ref Indexed at

  1. Cameron, F. L., K. Gerasimidis, A. Papangelou and D. Missiou, et al. "Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with C rohn's disease." Aliment Pharmacol Ther 37 (2013): 622-629.

Google Scholar Cross Ref Indexed at

  1. Vasseur, Francis, Corinne Gower-Rousseau, Gwenola Vernier-Massouille and Jean Louis Dupas, et al. "Nutritional status and growth in pediatric Crohn's disease: A population-based study." Am J Gastroenterol 105 (2010): 1893-1900.

Google Scholar Cross Ref Indexed at

  1. Singh, Siddharth, Parambir S. Dulai, Amir Zarrinpar and Sonia Ramamoorthy, et al. "Obesity in IBD: Epidemiology, pathogenesis, disease course and treatment outcomes." Nat Rev Gastroenterol Hepatol 14 (2017): 110-121.

Google Scholar Cross Ref Indexed at

  1. Bhalme, Mahesh, Abhishek Sharma, Richard Keld and Robert Willert, et al. "Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn’s disease?." Eur J Gastroenterol Hepatol 25 (2013): 543-549.

Google Scholar Cross Ref Indexed at

Google Scholar citation report
Citations: 77

Journal of Inflammatory Bowel Diseases & Disorders received 77 citations as per Google Scholar report

Journal of Inflammatory Bowel Diseases & Disorders peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward